GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bristol-Myers Squibb Co (LIM:BMY) » Definitions » Gross Profit

Bristol-Myers Squibb Co (LIM:BMY) Gross Profit : $34,332 Mil (TTM As of Dec. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Bristol-Myers Squibb Co Gross Profit?

Bristol-Myers Squibb Co's gross profit for the three months ended in Dec. 2024 was $7,530 Mil. Bristol-Myers Squibb Co's gross profit for the trailing twelve months (TTM) ended in Dec. 2024 was $34,332 Mil.

Gross Margin % is calculated as gross profit divided by its revenue. Bristol-Myers Squibb Co's gross profit for the three months ended in Dec. 2024 was $7,530 Mil. Bristol-Myers Squibb Co's Revenue for the three months ended in Dec. 2024 was $12,342 Mil. Therefore, Bristol-Myers Squibb Co's Gross Margin % for the quarter that ended in Dec. 2024 was 61.01%.

Bristol-Myers Squibb Co had a gross margin of 61.01% for the quarter that ended in Dec. 2024 => Durable competitive advantage

During the past 13 years, the highest Gross Margin % of Bristol-Myers Squibb Co was 78.57%. The lowest was 69.10%. And the median was 73.37%.


Bristol-Myers Squibb Co Gross Profit Historical Data

The historical data trend for Bristol-Myers Squibb Co's Gross Profit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bristol-Myers Squibb Co Gross Profit Chart

Bristol-Myers Squibb Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Gross Profit
Get a 7-Day Free Trial Premium Member Only Premium Member Only 30,745.00 36,445.00 36,022.00 34,313.00 34,332.00

Bristol-Myers Squibb Co Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Gross Profit Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8,732.00 8,933.00 8,934.00 8,935.00 7,530.00

Competitive Comparison of Bristol-Myers Squibb Co's Gross Profit

For the Drug Manufacturers - General subindustry, Bristol-Myers Squibb Co's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bristol-Myers Squibb Co's Gross Profit Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Bristol-Myers Squibb Co's Gross Profit distribution charts can be found below:

* The bar in red indicates where Bristol-Myers Squibb Co's Gross Profit falls into.



Bristol-Myers Squibb Co Gross Profit Calculation

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

Bristol-Myers Squibb Co's Gross Profit for the fiscal year that ended in Dec. 2024 is calculated as

Gross Profit (A: Dec. 2024 )=Revenue - Cost of Goods Sold
=48300 - 13968
=34,332

Bristol-Myers Squibb Co's Gross Profit for the quarter that ended in Dec. 2024 is calculated as

Gross Profit (Q: Dec. 2024 )=Revenue - Cost of Goods Sold
=12342 - 4812
=7,530

Gross Profit for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $34,332 Mil.

Gross Profit is the numerator in the calculation of Gross Margin.

Bristol-Myers Squibb Co's Gross Margin % for the quarter that ended in Dec. 2024 is calculated as

Gross Margin % (Q: Dec. 2024 )=Gross Profit (Q: Dec. 2024 ) / Revenue (Q: Dec. 2024 )
=(Revenue - Cost of Goods Sold) / Revenue
=7,530 / 12342
=61.01 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Bristol-Myers Squibb Co  (LIM:BMY) Gross Profit Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Bristol-Myers Squibb Co had a gross margin of 61.01% for the quarter that ended in Dec. 2024 => Durable competitive advantage


Bristol-Myers Squibb Co Gross Profit Related Terms

Thank you for viewing the detailed overview of Bristol-Myers Squibb Co's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.


Bristol-Myers Squibb Co Business Description

Address
Route 206 and Province Line Road, Princeton, New Jersey, NJ, USA, 08543
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.